Literature DB >> 20064988

Fulminant hepatitis E in a woman taking oral contraceptive medication.

Maria Luisa Mateos Lindemann1, Javier Graus Morales, Salceda Fernández-Barredo, Mario Rodríguez Domínguez, Fernando García de la Hoz, Philippe Halfon, Maria Teresa Pérez Gracia.   

Abstract

We describe a fulminant autochthonous hepatic failure caused by hepatitis E (HEV) in a patient admitted in our hospital for liver-transplant evaluation. The only risk factor recorded for this severe course was the use of oral contraceptives that are known to mimic a hormonal status similar to pregnancy. The diagnosis was based on the presence of IgG and IgM anti-HEV in the serum of the patient and confirmed by the isolation of a strain of HEV genotype 3f from a blood sample obtained the fourth day after hospital admission. HEV genotype 3 is present in human and swine populations in Spain. The patient began to recover while waiting for a liver transplant. To our knowledge, this is the first report of fulminant hepatitis E in a non-pregnant European patient on oral contraceptives.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20064988      PMCID: PMC2803502          DOI: 10.4269/ajtmh.2010.09-0436

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  19 in total

1.  HEV identified in serum from humans with acute hepatitis and in sewage of animal origin in Spain.

Authors:  S Pina; M Buti; M Cotrina; J Piella; R Girones
Journal:  J Hepatol       Date:  2000-11       Impact factor: 25.083

Review 2.  Hepatitis E indigenous to economically developed countries: to what extent a zoonosis?

Authors:  Chong Gee Teo
Journal:  Curr Opin Infect Dis       Date:  2006-10       Impact factor: 4.915

Review 3.  Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis.

Authors:  Ling Lu; Chunhua Li; Curt H Hagedorn
Journal:  Rev Med Virol       Date:  2006 Jan-Feb       Impact factor: 6.989

4.  Hepatitis-E-associated fulminant hepatic failure in non-pregnant young women.

Authors:  J G Zijlstra; E B Haagsma; J E Tulleken; T S van der Werf
Journal:  Lancet       Date:  1997-07-26       Impact factor: 79.321

5.  Detection of hepatitis E virus in patients sera in southern Spain.

Authors:  M T Pérez-Gracia; M S García-Valdivia; F Galán; M A Rodríguez-Iglesias
Journal:  Acta Virol       Date:  2004       Impact factor: 1.162

6.  Detection of hepatitis E virus shedding in feces of pigs at different stages of production using reverse transcription-polymerase chain reaction.

Authors:  Salceda Fernández-Barredo; Carolina Galiana; Angel García; Santiago Vega; María Teresa Gómez; María Teresa Pérez-Gracia
Journal:  J Vet Diagn Invest       Date:  2006-09       Impact factor: 1.279

Review 7.  Hepatitis E: an emerging infection in developed countries.

Authors:  Harry R Dalton; Richard Bendall; Samreen Ijaz; Malcolm Banks
Journal:  Lancet Infect Dis       Date:  2008-11       Impact factor: 25.071

8.  Hepatitis E virus infection and fulminant hepatic failure during pregnancy.

Authors:  Nishat Jilani; Bhudev C Das; Syed A Husain; Usha K Baweja; Debashish Chattopadhya; Ram K Gupta; Sarita Sardana; Premashis Kar
Journal:  J Gastroenterol Hepatol       Date:  2007-05       Impact factor: 4.029

Review 9.  [Hepatitis E virus: zoonotic implications].

Authors:  Nereida Jiménez de Oya; Estela Escribano-Romero; Ana Belén Blázquez; Juan Carlos Saiz
Journal:  Gastroenterol Hepatol       Date:  2007 Aug-Sep       Impact factor: 2.102

10.  Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection.

Authors:  Sharda Patra; Ashish Kumar; Shubha Sagar Trivedi; Manju Puri; Shiv Kumar Sarin
Journal:  Ann Intern Med       Date:  2007-07-03       Impact factor: 25.391

View more
  8 in total

Review 1.  Host immune status and response to hepatitis E virus infection.

Authors:  Lisa J Krain; Kenrad E Nelson; Alain B Labrique
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

Review 2.  Female gender in the setting of liver transplantation.

Authors:  Kryssia Isabel Rodríguez-Castro; Eleonora De Martin; Martina Gambato; Silvia Lazzaro; Erica Villa; Patrizia Burra
Journal:  World J Transplant       Date:  2014-12-24

Review 3.  Hepatitis E virus infection: Epidemiology and treatment implications.

Authors:  Ga Young Lee; Kittiyod Poovorawan; Duangnapa Intharasongkroh; Pattaratida Sa-Nguanmoo; Sompong Vongpunsawad; Chintana Chirathaworn; Yong Poovorawan
Journal:  World J Virol       Date:  2015-11-12

Review 4.  Current Knowledge on Hepatitis E.

Authors:  María Teresa Pérez-Gracia; Mario García; Beatriz Suay; María Luisa Mateos-Lindemann
Journal:  J Clin Transl Hepatol       Date:  2015-06-15

Review 5.  Epidemiology of Hepatitis E Virus in European Countries.

Authors:  Daniele Lapa; Maria Rosaria Capobianchi; Anna Rosa Garbuglia
Journal:  Int J Mol Sci       Date:  2015-10-27       Impact factor: 5.923

Review 6.  Hepatitis E Virus in Industrialized Countries: The Silent Threat.

Authors:  Pilar Clemente-Casares; Carlota Ramos-Romero; Eugenio Ramirez-Gonzalez; Antonio Mas
Journal:  Biomed Res Int       Date:  2016-12-14       Impact factor: 3.411

Review 7.  Hepatitis E in High-Income Countries: What Do We Know? And What Are the Knowledge Gaps?

Authors:  Lisandru Capai; Rémi Charrel; Alessandra Falchi
Journal:  Viruses       Date:  2018-05-25       Impact factor: 5.048

8.  Full coding hepatitis E virus genotype 3 genome amplification method.

Authors:  M Muñoz-Chimeno; J E Forero; J M Echevarría; J L Muñoz-Bellido; L Vázquez-López; L Morago; M C García-Galera; A Avellón
Journal:  J Virol Methods       Date:  2016-01-16       Impact factor: 2.014

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.